Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
J Clin Microbiol. 2010 Jul;48(7):2515-23. doi: 10.1128/JCM.02286-09. Epub 2010 May 26.
Influenza virus diagnosis has traditionally relied on virus isolation in chicken embryo or cell cultures. Many laboratories have adopted rapid molecular methods for detection of influenza viruses and discontinued routine utilization of the relatively slow viral culture methods. We describe an influenza A virus reporter cell line that contributes to more efficient viral detection in cell culture. Madin-Darby canine kidney (MDCK) cells were engineered to constitutively produce an influenza virus genome-like luciferase reporter RNA driven by the canine RNA polymerase I promoter. Induction of a high level of luciferase activity was detected in the Luc9.1 cells upon infection with various strains of influenza A virus, including 2009 H1N1 pandemic and highly pathogenic H5N1 virus. In contrast, infection with influenza B virus or human adenovirus type 5 did not induce significant levels of reporter expression. The reporter Luc9.1 cells were evaluated in neutralizing antibody assays with convalescent H3N2 ferret serum, yielding a neutralization titer comparable to that obtained by the conventional microneutralization assay, suggesting that the use of the reporter cell line might simplify neutralization assays by facilitating the establishment of infectious virus endpoints. Luc9.1 cells were also used to determine the susceptibility of influenza A viruses to a model antiviral drug. The equivalence to conventional antiviral assay results indicated that the Luc9.1 cells could provide an alternative cell-based platform for high-throughput drug discovery screens. In summary, the MDCK-derived Luc9.1 reporter cell line is highly permissive for influenza A virus replication and provides a very specific and sensitive approach for simultaneous detection and isolation of influenza A viruses as well as functional evaluation of antibodies and antiviral molecules.
流感病毒的诊断传统上依赖于在鸡胚或细胞培养物中进行病毒分离。许多实验室已经采用了快速分子方法来检测流感病毒,并停止了相对较慢的病毒培养方法的常规使用。我们描述了一种流感 A 病毒报告细胞系,它有助于更有效地在细胞培养中检测病毒。Madin-Darby 犬肾 (MDCK) 细胞被工程改造为组成型产生流感病毒基因组样荧光素酶报告 RNA,由犬 RNA 聚合酶 I 启动子驱动。在感染各种流感 A 病毒株,包括 2009 年 H1N1 大流行和高致病性 H5N1 病毒时,Luc9.1 细胞中检测到高水平的荧光素酶活性诱导。相比之下,感染流感 B 病毒或人腺病毒 5 型不会诱导显著水平的报告基因表达。报告基因 Luc9.1 细胞在与恢复期 H3N2 雪貂血清的中和抗体测定中进行了评估,产生的中和效价与传统微量中和测定相当,这表明报告细胞系的使用可能通过简化感染病毒终点的建立来简化中和测定。Luc9.1 细胞也用于确定流感 A 病毒对模型抗病毒药物的敏感性。与传统抗病毒测定结果的等效性表明,Luc9.1 细胞可为高通量药物发现筛选提供替代的基于细胞的平台。总之,MDCK 衍生的 Luc9.1 报告细胞系对流感 A 病毒复制高度允许,并提供了一种非常特异和敏感的方法,用于同时检测和分离流感 A 病毒以及评估抗体和抗病毒分子的功能。